- Report
- February 2024
- 250 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- May 2024
- 179 Pages
Global
From €4756EUR$4,950USD£4,090GBP
- Report
- November 2023
- 144 Pages
Global
From €2401EUR$2,499USD£2,065GBP
- Report
- January 2024
- 143 Pages
Global
From €4084EUR$4,250USD£3,511GBP
- Report
- March 2024
- 189 Pages
Global
From €3242EUR$3,374USD£2,788GBP
€3602EUR$3,749USD£3,097GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- October 2023
- 172 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1922EUR$2,000USD£1,652GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,239GBP
- Report
- November 2023
- 184 Pages
Global
From €2402EUR$2,500USD£2,066GBP
- Report
- February 2023
- 126 Pages
Global
From €5717EUR$5,950USD£4,916GBP
- Report
- September 2019
- 160 Pages
Latin America
From €3988EUR$4,150USD£3,429GBP
- Report
- February 2021
- 125 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- April 2023
- 246 Pages
Global
From €7206EUR$7,500USD£6,197GBP
- Report
- August 2022
- 118 Pages
Global
From €4324EUR$4,500USD£3,718GBP
- Report
- August 2022
- 118 Pages
Global
From €4324EUR$4,500USD£3,718GBP
- Report
- September 2020
- 50 Pages
China
From €2498EUR$2,600USD£2,148GBP
- Report
- August 2022
- 120 Pages
Global
From €2402EUR$2,500USD£2,066GBP
- Report
- February 2021
- 30 Pages
Global
From €3839EUR$3,995USD£3,301GBP
- Report
- March 2021
- 130 Pages
Global
From €10565EUR$10,995USD£9,084GBP
Erythropoietin is a hormone produced by the kidneys and liver that stimulates the production of red blood cells. It is used to treat anemia caused by kidney and liver disorders, such as chronic kidney disease and end-stage renal disease. It is also used to treat anemia caused by chemotherapy and other cancer treatments. Erythropoietin is available in both injectable and oral forms, and is often prescribed in combination with other drugs.
Erythropoietin is a widely used drug in the treatment of anemia caused by kidney and liver disorders. It is used to increase the production of red blood cells, which can help improve the patient's quality of life. It is also used to reduce the need for blood transfusions, which can be costly and time-consuming.
Several companies are involved in the production and distribution of erythropoietin. These include Amgen, Biogen, Johnson & Johnson, Novartis, Pfizer, and Roche. These companies produce and market erythropoietin under various brand names, such as Epogen, Procrit, and Aranesp. Show Less Read more